CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-02 | Fattaey Ali Ph.D. President & CEO | Grant or award · Nonqualified stock option (right to buy) | +400,000 | 600,000 | ||
| 2014-04-02 | MCNAB JAMES R Director | Gift | −30,000 | 1,049,688 | ||
| 2014-02-18 | GRAY MICHAEL CBO and CFO | Grant or award · Employee stock option (right to buy) | +60,000 | 60,000 | ||
| 2014-02-18 | GRAY MICHAEL CBO and CFO | Grant or award · Non-qualified stock option (right to buy) | +120,000 | 180,000 | ||
| 2014-02-18 | Viner Jaye Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2014-02-18 | Viner Jaye Chief Medical Officer | Grant or award · Nonqualified Stock Option (right to buy) | +120,000 | 180,000 | ||
| 2014-02-18 | Viner Jaye Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2014-02-18 | Viner Jaye Chief Medical Officer | Grant or award · Nonqualified Stock Option (right to buy) | +120,000 | 180,000 | ||
| 2014-02-18 | Fattaey Ali Ph.D. President & COO | Grant or award · Employee stock option (right to buy) | +100,000 | 100,000 | ||
| 2014-02-18 | Fattaey Ali Ph.D. President & COO | Grant or award · Nonqualified stock option (right to buy) | +200,000 | 300,000 | ||
| 2014-02-18 | PASSERI DANIEL R CEO and Director | Grant or award · Employee stock option (right to buy) | +100,000 | 100,000 | ||
| 2014-02-18 | PASSERI DANIEL R CEO and Director | Grant or award · Non-qualified stock option (right to buy) | +200,000 | 300,000 | ||
| 2014-02-14 | Dentzer James E Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +650,000 | 650,000 | ||
| 2014-01-27 | Martell Robert Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2014-01-27 | MCNAB JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +85,000 | 85,000 | ||
| 2014-01-27 | TOBIN JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2014-01-27 | KAITIN KENNETH I Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2014-01-27 | Rubin Marc Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2014-01-27 | GREENACRE MARTYN D Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2014-01-27 | Pienta Kenneth Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 |
Page 13 of 17 · 326 trades